Archive for May, 2011

Zeroing in on Alzheimer’s disease

Recently the number of genes known to be associated with Alzheimer’s disease has increased from four to eight, including the MS4A gene cluster on chromosome 11. New research has expanded on this using a genome-wide association study to find a novel location within the MS4A gene cluster which is associated with Alzheimer’s disease.

Alzheimer’s Association offering new support program in Hilton

The Alzheimer’s Association of Rochester will be offering a support program specifically for people with early to middle stages of memory loss.

Potential new drug candidate found for Alzheimer’s disease

( University of California - San Diego ) Researchers at the University of California, San Diego, the Medical University of South Carolina and American Life Science Pharmaceuticals of San Diego have demonstrated that oral administration of a cysteine protease inhibitor, E64d, not only reduces the build-up of beta-amyloid in the brains of animal models for Alzheimer’s disease, but also results in …

Research and Markets: The 2011 10th International Conference on Alzheimer’s and Parkinson’s Diseases: Post-Conference …

Research and Markets has announced the addition of GlobalData ’s new report “The 10th International Conference on Alzheimer’s and Parkinson’s Diseases: Post-Conference Review and Analysis” to their offering.

Neurodegeneration From Noncoding RNA May Promote Alzheimer’s Disease

Researchers pinpoint a small RNA that spurs cells to manufacture a particular splice variant of a key neuronal protein, potentially promoting Alzheimer’s disease (AD) or other types of neurodegeneration.

Scientists come closer to finding cause of Alzheimer’s disease

Washington, May 31 (ANI): Scientists have come a step closer to finding out what the causes of Alzheimer’s disease are.

Alzheimer’s center delayed

Plans to build a memory care center in Sioux Falls for patients suffering from Alzheimer’s and other forms of dementia have been delayed while developers work through regulatory issues with the state, according to a company official. Construction was to have begun last fall on land off of Minnesota Avenue, at West 81st Street and South Audie Avenue, to open the Esprit of Sioux Falls facility …

Study finds novel site within MS4A gene cluster, confirms presence of SNP linked with Alzheimer’s

Recently the number of genes known to be associated with Alzheimer’s disease has increased from four to eight, including the MS4A gene cluster on chromosome 11.

Family shares what living with Alzheimer’s is really like

MARIETTA - Mildred Rutherford, 93, grew up in Austell as the eldest of five children, and as an adult, worked as a Sears, Roebuck and Co. statistician for more than 40-years before retiring in the …

Can music help Alzheimer’s patients build memories?

Music triggers memories, even for people with Alzheimer’s disease. A big band recording can help them remember their lives when the song was new

Alzheimer’s patient gets bail on alleged manslaughter charge in nursing home

WINNIPEG - An Alzheimer’s patient who has been charged with manslaughter in a death at a Winnipeg personal care home has been granted bail.

Arrowing In On Alzheimer’s Disease

Recently the number of genes known to be associated with Alzheimer’s disease has increased from four to eight, including the MS4A gene cluster on chromosome 11. New research published in BioMed Central’s open access journal Genome Medicine has expanded on this using a genome-wide association study (GWAS) to find a novel location within the MS4A gene cluster which is associated with Alzheimer’s …

Unique Alzheimer Study Of Four Siblings

Four siblings in a family affected by early-onset Alzheimer’s have been studied by a group of researchers at Karolinska Institutet in Sweden. This has been a unique opportunity to make comparative studies and to monitor the development of the disease over a prolonged period of time.

Marguerite Manteau-Rao: The ‘Presence’ Approach to Care With Alzheimer’s and Other Types of Dementia

Support for Alzheimer’s caregivers has mostly been in the form of information sharing, skills training, stress-management techniques, peer-support and behavior modification solutions. While important, these external interventions tend to not stick.

Alzheimer’s Society Comment On Care Quality Commission Inspection, UK

The Care Quality Commission (CQC) has identified major failings in the first 12 of its 100 reports into the quality of elderly care in hospitals in England. The report identified three hospitals as failing to meet essential standards required by law

TGen study identifies compounds that could slow down Alzheimer’s disease

( The Translational Genomics Research Institute ) A family of naturally occurring plant compounds could help prevent or delay memory loss associated with Alzheimer’s disease, according to a new study by the Translational Genomics Research Institute (TGen).

Alzheimer’s Risk Gene Disrupts Brain’s Wiring 50 Years Before Disease Hits Seniors

May 26, 2011 - What if you were told you carried a gene that increases your risk for Alzheimer’s disease? And what if you were told this gene starts to do its damage not when you’re a senior citizen but when you’re young? Brace yourself, here it comes…

Stress may increase risk for Alzheimer’s disease

( Max-Planck-Gesellschaft ) Stress promotes neuropathological changes that are also seen in Alzheimer’s disease. Scientists from the Max Planck Institute of Psychiatry in Munich have discovered that the increased release of stress hormones in rats leads to generation of abnormally phosphorylated tau protein in the brain and ultimately, memory loss.

Alzheimer’s Disease Drug Developed At Roskamp Institute Approved For Key Clinical Trial Funding In Europe

An international research consortium led by Trinity College Dublin (Ireland) today announced the selection for funding of a large-scale European clinical trial of Nilvadipine, an Alzheimer’s disease drug developed at the Roskamp Institute in Sarasota.

Understanding Alzheimer’s disease

Alzheimer’s disease is a progressive, degenerative disease of the brain for which there is no cure. It is the most common form of dementia, affecting memory, language, reasoning and the ability to perform routine tasks.